Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 12/2010

01-12-2010 | Healthcare Policy and Outcomes

2010 SSO Presidential Address: Subspecialty Certificate in Advanced Surgical Oncology

Author: Fabrizio Michelassi, MD

Published in: Annals of Surgical Oncology | Issue 12/2010

Login to get access

Excerpt

The directors of the American Board of Surgery unanimously approved the proposal for a subspecialty certificate in advanced surgical oncology at their meeting in Philadelphia in June 2009. What events preceded this approval? What other hurdles need to be surmounted before certification in surgical oncology becomes a reality? …
Literature
1.
Copeland EM, III. Surgical oncology: a specialty in evolution. Ann Surg Oncol. 1999;6:424–32.PubMed
2.
Metadata
Title
2010 SSO Presidential Address: Subspecialty Certificate in Advanced Surgical Oncology
Author
Fabrizio Michelassi, MD
Publication date
01-12-2010
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 12/2010
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-1286-7

Other articles of this Issue 12/2010

Annals of Surgical Oncology 12/2010 Go to the issue

Melanomas

The Prognostic Significance of Nonsentinel Lymph Node Metastasis in Melanoma

Hepatobiliary Tumors

Surgical Management of Hepatic Neuroendocrine Tumor Metastasis: Results from an International Multi-Institutional Analysis

Head and Neck Oncology

Recurrent Pleomorphic Adenoma: Results of Surgical Treatment

Translational Research and Biomarkers

Jun Activation Domain Binding Protein 1 is Overexpressed from the Very Early Stages of Hepatocarcinogenesis

Hepatobiliary Tumors

Exploration of Potential Genomic Portraits Associated with Intrahepatic Recurrence in Human Hepatocellular Carcinoma

Pancreatic Tumors

MicroRNA-203 Expression as a New Prognostic Marker of Pancreatic Adenocarcinoma